www.varchev.com

Hedge funds with interest in GE, Facebook and more

Rating:

12345
Loading...

Top hedge funds are trying to beat the market by betting on several shares this year. General Electric, Facebook and Biogen are just part of the broad choice of hedge funds to improve the efficiency of individual stock selection.

The list of the best funds since the beginning of the year and for the past three years includes Aisling Capital, Boxer Capital and RA Capital Management.

Figures do not show direct return on shares, but their ability to successfully select individual stocks. Next, the yield is calculated by comparing the shares' performance in the funds with that of ETFs by sector. In this case, Symmetric estimates this capability of nearly 1,000 hedge funds with an indicator called StockAlpha.

These hidden "jewels" materialize as top 10 hedge funds with a strong performance this year, as well as over the past three years. Last week, they registered their new subscriptions for the first quarter, and below we can see the top ten positions the funds have added for the last quarter.

Hedge funds disclose their positions four times a year in records to the US Financial Supervision Commission, and the information then goes public in 45 days after the end of each quarter.

Steadfast Capital has invested $ 153 million at General Electric at the end of the last quarter. The fund has also added new positions to PG & E, Burlington Stores and Facebook. Steadfast managed assets for about $ 10.6 billion, with the fund's performance at 23.4 percent from the beginning of the year.

RA Capital Management and Boxer Capital focus on the health and biotech sectors. RA are investing in Sage Therapeutics and Axsome Therapeutics. Since the beginning of the year Axsome is up 751% and Sage 79%. Boxer added to their Biogen portfolio, which is down 21%.

Source: CNBC


 Trader Martin Nikolov

Read more:

RECCOMEND WAS THIS POST USEFUL FOR YOU?
If you think, we can improve that section,
please comment. Your oppinion is imortant for us.
WARNING: Any news, opinions, research, data or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. Varchev Finance Ltd. expressly disclaims any liability for any lost principal or profits which may arise directly or indirectly from the use of or reliance on such information. Varchev Finance Ltd. may provide information, quotes, references and links to or from other sites and blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the sites, blogs or other sources of information.
Varchev Finance

London


25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256

Universal numbers

World Financial Markets - 0700 17 600    Varchev Exchange - 0700 115 44

Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.

Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006

The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.


Disclaimer:

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

chat with dealer
chat with dealer
Cookies policy